483
Hugel Inc.Hugel Inc. – FDA 483, Aug 20, 2021
Record Details
Hugel, Inc. in Chuncheon, Gangwon, Korea, was inspected for drug substance and drug product manufacturing. The inspection revealed significant issues related to Clostridium botulinum spore control, including inadequate containment, decontamination, and environmental monitoring. Additionally, the firm had deficiencies in OOS investigations, logbook management, cell bank comparability, and batch filling time controls.
View Company Profile
ID · 21fcd217-7913-4979-9020-de9e0f5af888
Violation Codes2
21 CFR 21021 CFR 211
Full citation text and observation details available on the Dashboard.
Other documents for Hugel Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.